Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
activities of daily living
advances in neurology
adverse drug reaction
akathisia
albumin
alcohol
alcoholism
alpha-synuclein
alternative medicine
Alzheimer's disease
Alzheimer's disease, preclinical
Alzheimer's disease, risk factors in
Alzheimer's disease, treatment of
amyloid beta protein
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, differential diagnosis
amyotrophic lateral sclerosis, etiology of
amyotrophic lateral sclerosis, prognosis
amyotrophic lateral sclerosis, treatment of
aneurysm
aneurysm, intracranial
aneurysm, intracranial, delayed cerebral ischemia with
aneurysm, intracranial, treatment of
angiotensin II receptor blocker
antibiotics
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
antihypertensive
antioxidant
apolipoprotein E
apoptosis
aptiganel
arm weakness
ascorbic acid
aspirin
atherosclerosis, generalized
autonomic dysfunction
axonal degeneration
biologic markers
BiPAP
blacks
blood pressure
body temperature
brain atrophy
brain transplantation
bulbar palsy
bulbar palsy, progressive
burning paresthesia
caffeine
calcium antagonist
calcium antagonist, side effects of
cardiac arrest
cardiac arrest and resuscitation
caspases
CAT scan
CAT scan, abnormal
CAT scan, disappearing lesion on
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, xenon-enhanced
cerebral blood flow
cerebral edema
cerebral embolism
cerebral infarction
cerebral ischemia
cerebrospinal fluid
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, complications with
cerebrovascular accident, neonatal
cerebrovascular accident, pathophysiology
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, severity
cerebrovascular accident, spontaneous improvement after
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time of presentation
cerebrovascular accident, volume
cerebrovascular accident, work up for
cerebrovascular disease
cerebrovascular disease, risk factors in
cerebrovascular disease, surgical treatment of
cholesterol
cholesterol, LDL
cigarette smoking
citicoline
clinical trials
cognition
coma
controversies in neurology
cooling therapy
coronary artery disease
craniectomy, decompressive
crying, pathologic
DATATOP study
degenerative diseases of CNS
dementia
dementia, cerebrovascular disease causing
dementia, incidence
dementia, prevention of
dementia, treatment of
deprenyl
diabetes mellitus
diet
dimebon
disability, neurological
distal muscle weakness
dopamine agonist
dopamine receptor, D2
drug induced neurologic disorders
dying
dysarthria
dyskinesia, buccal lingual facial
dysphagia
efficacy
embolism
emergencies, neurologic
emergency medical technicians
emotional lability
encephalopathy, post traumatic
endarterectomy, carotid
endarterectomy, carotid-complications of
endarterectomy, carotid-indications for
endarterectomy, carotid-long term results
endarterectomy, carotid-morbidity and mortality with
endovascular therapy
enzyme inhibition
epidemiology of neurology
excitotoxin
fasciculation
fatigue
fever
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibroblast growth factor
fish
flavonoids
foot drop
free radical
fruits
fumarate
gadolinium
gender
Glasgow coma score
glutamic acid
head injury
head injury, evaluation of
head injury, management of
head injury, pathophysiology of
head injury, prevention
head injury, prognosis in
headache
headache, treatment of
hemodilution
hemorrhage, intracranial, newborn
hemorrhage, periventricular
heparin
heralding manifestation
herpes simplex encephalitis, diagnosis of
histamine-2 receptor blockers
HMGcoA reductase inhibitors
hormone replacement
hospice
hydrocephalus
hyperreflexia
hypertension
hyperthermia
hyperuricemia
hypotension, systemic
hypothermia
hypoxic encephalopathy
iatrogenic neurologic disorders
ibuprofen
immunomodulation
indomethacin
intellectual deficit
intracranial pressure monitoring
intraventricular hemorrhage
intrinsic hand muscles, wasting of
ischemic penumbra
Kleine-Levin syndrome
lacunar infarction
laughing, pathologic
L-dopa
leg weakness, unilateral
Lewy body
Lewy body disease, diffuse
life expectancy
lipid lowering agent
lithium
low birth weight
lubeluzole
magnesium sulfate
melatonin
mental status, evaluation of
middle cerebral artery, occlusion of
migraine, prophylaxis
migraine, treatment of
mild cognitive impairment
minocycline
monoamine oxidase inhibitors
mortality
motor neuron disease
movement disorder, extrapyramidal
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, contrast enhanced
MRI, diffusion weighted
MRI, early changes in CVA
MRI, false negative
MRI, mismatch between perfusion/diffusion
MRI, perfusion
MRS
multiple sclerosis
multiple sclerosis, monosymptomatic
multiple sclerosis, pathogenesis
multiple sclerosis, relapsing
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
muscle wasting, diffuse
N-acetyl-L-aspartic acid
nerve growth factor
neuroendocrinology
neurologic disease
neurologic disease, diagnoses of
neurologic evaluation
neurologic examination
neurologic symptoms
neurologic testing
neuronal cell death
neuropathology
neuropathology, brain
neuropathy
neuroprotective agents
neurotransmitter
nicardipine
nimodipine
NMDA antagonists
NMDA receptors
nonsteroidal anti-inflammatory drug
old age, neurology of
pallidotomy
paresthesias
paresthesias, facial
Parkinson disease
Parkinson disease, diagnosis
Parkinson disease, drug induced
Parkinson disease, early symptoms
Parkinson disease, etiology of
Parkinson disease, nonmotor problems of
Parkinson disease, pathogenesis of
Parkinson disease, prognosis of
Parkinson disease, progression
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinsonism syndrome
pathology
pineal
piracetam
platelet inhibiting drugs
practice guidelines
pravastatin
preclinical
premarin
prevention of neurologic disorders
prognosis
psychological testing
rasagiline
rehabilitation for neurologic disorders
research
respirator
respiratory failure
review article
riluzole
risk factors
risk-benefit assessment
safety
seizure
seizure, treatment of
simvastatin
sinemet
single photon emission computed tomography
sleep
sleep pathology and physiology
smell
sodium-glucoe cotransporter-2 inhibitors
statin therapy
stimulant drugs
streptokinase
stroke unit
stroke, progression of
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
subthalamic nucleus
subthalamic nucleus deep brain stimulation
synucleinopathy
tea
tetracycline
thrombolysis, mechanical
tissue plasminogen activator, intravenous
treatment of neurologic disorder
tremor, thalamic stimulation for suppression of
tripping
vasospasm, cerebral
vegetables
vestibular function, tests of
vitamin A
vitamin D
vitamin E
vitamin supplementation
whites
wine
Showing articles 1350 to 1400 of 3460 << Previous Next >>

Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005

Time to Hospital Arrival, Use of Thrombolytics, and In-Hospital Outcomes in Ischemic Stroke
Neurol 64:2115-2120, Qureshi,A.I.,et al, 2005

Neurologic Manifestations in Welders with Pallidal MRI T1 Hyperintensity
Neurol 64:2033-2039,2001, Josephs,K.A.,et al, 2005

Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia
Stroke 36:1441-1446, Daffertshofer,M.,et al, 2005

Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
Stroke 36:1512-1518, Wojner-Alexandrov,A.,et al, 2005

Predictors of Early Arterial Reocclusion After Tissue Plasminogen Activator-Induced Recanalization in Acute Ischemic Stroke
Stroke 36:1452-1456, Rubiera,M.,et al, 2005

Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke, Results of the MERCI Trial
Stroke 36:1432-1440, Smikth,W.D.,et al, 2005

Lymphocytic Choriomeningitis Virus Infection in Organ Transplant Recipients-Massachusetts, Rhode Island, 2005
MMWR 54:537-539, , 2005

Statin Use and the Risk of Incident Dementia
Arch Neurol 62:1047-1051, Rea,T.D.,et al, 2005

CT and MRI Findings of Intracranial Lymphoma
AJR 184:1679-1685, Slone,H.W.,et al, 2005

Clinicopath Conf,Encephalomyelitis Due to West Nile Virus and CLL, Case 22-2005
NEJM 353:287-295, Hollande,H.,et al, 2005

Diffusion-Weighted MR Imaging of Early Methotrexate-Related Neurotoxicity in Children
AJNR 26:1686-1689, Fisher,M.J.,et al, 2005

Pediatric Central Nervous System Posttransplant Lymphoproliferative Disorder
AJNR 26:1695-1697, Brennan,.C.,et al, 2005

Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
JAMA 293:557-564,615, Chang,S.M.,et al, 2005

Encephalopathy and Peripheral Neuropathy Following Diethylene Glycol Ingestion
Neurol 64:1273-1275, Hasbani,M.J.,et al, 2005

Methyl Bromide Intoxication Causes Reversible Symmetric Branstem and Cerebellar MRI Lesions
Neurol 64:1279-1281, Geyer,H.L.,et al, 2005

Neuropathy Resembling CIDP in Patients Receiving Tumor Necrosis Factor-a Blockers
Neurol 64:1468-1470, Richez,C.,et al, 2005

Reversal of Warfarin-Induced Anticoagulation with Factor VIIa Prior to rt-PA in Acute Stroke
Neurol 64:1480-1481, Talkad,A.,et al, 2005

Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome
AJNR 26:880-884, Zaidat,O.O.,et al, 2005

Mechanical Thrombectomy for Acute Stroke
AJNR 26:875-879, Versnick,E.J.,et al, 2005

Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine
AJNR 26:695-701,687, Tardieu,M.,et al, 2005

Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005

Does This Patient Have Myasthenia Gravis?
JAMA 293:1906-1914, Scherer,K.,et al, 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005

IV Thrombolysis in Patients with Acute Stroke Due to Spontaneous Carotid Dissection
Neurol 64:1612-1614, Georgiadis,D.,et al, 2005

FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005

Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease
Arch Neurol 62:753-757, Sparks,D.L.,et al, 2005

Prevalence of Leukoencephalopathy in Children Treated for Acute Lymphoblastic Leukemia with High-Dose Methotrexate
AJNR 26:1263-1269, Reddick,W.E.,et al, 2005

JC Virus Granule Cell Neuronopathy: A Novel Clinical Syndrome Distinct from Progressive Multifocal Leukoencephalopathy
Ann Neurol 57:576-580, Koralnik,I.J.,et al, 2005

Fatal Toxic Leukoencephalopathy: Clinical, Radiological, and Necropsy Findings in Two Patients
JNNP 76:1014-1016, Ryan,A.,et al, 2005

Utility of an Ultrafast Magnetic Resonance Imaging Protocol in Recent and Semi-Recent Strokes
JNNP 76:1002-1005,905, U-King-Im,J.M.,et al, 2005

Effect of Pravastatin on Cerebral Infarcts and White Matter Lesions
Neurol 64:1807-1809, ten Dam,V.H.,et al, 2005

Incidence of Contrast Nephropathy From Cerebral CT Angiography and CT Perfusion Imaging
Neurol 64:1805-1806, Josephson,S.A.,et al, 2005

Leukoencephalopathy From "Chasing the Dragon"
Neurol 64:1755, Halloran,O.,et al, 2005

HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke Outcomes
Stroke 36:1298-1300, Moonis,M.,et al, 2005

NOA-03 Trial of High-Dose Methotrexate in Primary Central Nervous System Lymphoma:Final Report
Ann Neurol 57:843-847, Herrlinger,W.,et al, 2005

tPA By Telephone: Extending the Benefits of a Comprehensive Stroke Center
Neurol 64:154-156, Frey,J.L.,et al, 2005

VZV Vasculopathy and Postherpetic Neuralgia
Neurol 64:21-25, Gilden,D.H.,et al, 2005

Expanding Indications for Statins in Cerebral Ischemia
Arch Neurol 62:67-72,23, Ovbiagele,B.,et al, 2005

Painful Peripheral Neuropathy Associated with Voriconazole Use
Arch Neurol 62:144-146, Tsiodras,S.,et al, 2005

Telemedicine for Safe and Extended Use of Thrombolysis in Stroke
Stroke 36:287-291, Audebert, H.J., et al, 2005

Aggressive Mechanical Clot Disruption
Stroke 36:292-296, Noser, E.A., et al, 2005

Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005

Combined IV and intra-arterial thrombolysis for acute ischemic stroke
Neurol 64:386-388, Flaherty, M.L., et al, 2005

Do the Brain Attack Coalition's Criteria for Stroke Centers Improve Care for Ischemic Stroke?
Neurol 64:422-427, Douglas, V.C., et al, 2005

A Trial of Metoclopramide vs Sumatriptan for the Emergency Department Treatment of Migraines
Neurol 64:463-468, Friedman, B.W., et al, 2005

Intraocular Haemorrhage after Thrombolysis
Lancet 365:330, Kaba, R.A., et al, 2005

Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005

Prioritizing interventions to Improve Rates of Thrombolysis for Ischemic Stroke
Neurol 64:654-659, California Acute Stroke Pilot Registry (CASPR) Inv, 2005



Showing articles 1350 to 1400 of 3460 << Previous Next >>